Alexopoulos, G. S., Abrams, R. C., Young, R. C. and Shamoian, C. A. (1988). Cornell Scale for Depression in Dementia. Biological Psychiatry, 23, 271–284.
Alexopoulos, G. S., Strein, J., Carpenter, D. and Dochtery, J. P. (2004). Expert Consensus Guideline Series: using antipsychotic agents in older patients. Journal of Clinical Psychiatry, 65, S4–104
Allard, J., Artero, S. and Ritchie, K. (2003). Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. International Journal of Geriatric Psychiatry, 18, 874–878.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
Arrindell, W. A. and Ettema, J. H. (1986). SCL-90. Manual for a Multidimensional Psychopathology-indicator. [In Dutch: Handleiding bij een multidimensionele psychopathologie-indicator]. Lisse: Swets and Zeitlinger.
Ballard, C. and DART AD investigators (2008). A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Medicine, 5, e76.
Beinhoff, U., Hilbert, V., Bittner, D., Gron, G. and Riepe, M. W. (2005). Screening for cognitive impairment: a triage for outpatient care. Dementia and Geriatric Cognitive Disorders, 20, 278–285.
Bierman, E. J. et al. (2007). The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? International Journal of Geriatric Psychiatry, 22, 1194–1200.
Brooks, J. O. and Hoblyn, J. C. (2007). Neurocognitive costs and benefits of psychotropic medications in older adults. Journal of Geriatric Psychiatry and Neurology, 20, 199–214.
Burdick, D. J. et al. (2005). Predictors of functional impairment in residents of assisted-living facilities: the Maryland Assisted Living study. Journals of Gerontology: A Biological Sciences and Medical Sciences, 60, 258–264.
Caballero, J., Hitchcock, M., Scharre, D., Beversdorf, D. and Nahata, M. C. (2006). Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study. Clinical Therapy, 28, 1695–1700.
Cohen, J. (1992). Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Earlbaum Associates.
Cooper, J. W., Freeman, M. H., Cook, C. L. and Burfield, A. H. (2007). Assessment of psychotropic and psychoactive drug loads and falls in nursing facility residents. Consultant Pharmacist, 22, 483–489.
Curran, H. V., Collins, R., Fletcher, S., Kee, S. C., Woods, B. and Iliffe, S. (2003). Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychological Medicine, 33, 1223–1237.
Dealberto, M. J., McAvay, G. J., Seeman, T. and Berkman, L. (1997). Psychotropic drug use and cognitive decline among older men and women. International Journal of Geriatric Psychiatry, 12, 567–574.
De Deyn, P. P. et al. (2004). Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry, 19, 115–126.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: a practical method of grading cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Hannesdottir, K. and Morris, R. G. (2007). Primary and secondary anosognosia for memory impairment in patients with Alzheimer's disease. Cortex, 43, 1020–1030.
Harrison, B. E. and Therrien, B. (2007). Effect of antipsychotic medication use on memory in patients with Alzheimer's disease: assessing the potential risk for accelerated recent autobiographical memory loss. Journal of Gerontological Nursing, 33, 11–20.
Hosia-Randell, H. and Pitkälä, K. (2005). Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs and Aging, 22, 793–800.
Kennedy, J. et al. (2005). Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia. International Journal of Geriatric Psychiatry, 20, 1020–1027.
Kok, R. M., Heeren, Th. J. and Van Hemert, A. M. (1993). De Geriatric Depression Scale. Tijdschrift voor Psychiatrie, 35, 416–421.
Kørner, A. et al. (2006). The Geriatric Depression Scale and the Cornell Scale for Depression in Dementia: a validity study. Nordic Journal of Psychiatry, 60, 360–364.
Lakey, S. L., Gray, S. L., Sales, A. E., Sullivan, J. and Hedrick, S. C. (2006). Psychotropic use in community residential care facilities: a prospective cohort study. American Journal of Geriatric Pharmacotherapy, 4, 227–235.
Lindeboom, J. and Jonker, C. (1989). Amsterdam Dementia Screening Test, Manual [In Dutch: Amsterdamse Dementie-screeningtest, handleiding]. Lisse: Swets and Zeitlinger.
Livingston, G., Walker, A. E., Katona, C. L. and Cooper, C. (2007). Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study. Journal of Neurology, Neurosurgery and Psychiatry, 78, 25–29.
Loewenstein, D. A., Rubert, M. P., Argüelles, T. and Duara, R. (1995). Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia. Archives of Clinical Neuropsychology, 10, 75–88.
McAndrews, M. P, Weissm, R. T., Sandor, P., Taylor, A., Carlen, P. L. and Shapiro, C. M. (2003). Cognitive effects of long-term benzodiazepine use in older adults. Human Psychopharmacology, 18, 51–57.
Mossello, E. et al. (2008). Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease? Dementia and Geriatric Cognitive Disorders, 25, 372–379.
Palmer, K., Berger, A. K., Monastero, R., Winblad, B., Bäckman, L. and Fratiglioni, L. (2007). Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology, 68, 1596–1602.
Reekum, R. et al. (2002). A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. International Psychogeriatrics, 14, 197–210.
Ruths, S., Straand, J. and Nygaard, H. A. (2001). Psychotropic drug use in nursing homes: diagnostic indications and variations between institutions. European Journal of Clinical Pharmacology, 57, 523–528.
Ruths, S., Straand, J., Nygaard, H. A. and Aarsland, D. (2008). Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study – The Bergen District Nursing Home Study (BEDNURS). International Journal of Geriatric Psychiatry, 23, 889–895.
Schäufele, M., Bickel, H. and Weyerer, S. (2002). Which factors influence cognitive decline in older adults suffering from dementing disorders? International Journal of Geriatric Psychiatry, 17, 1055–1063.
Schneider, L. S., Dagerman, K. and Insel, P. S. (2006a). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191–210.
Schneider, L. S. et al. . CATIE-AD Study Group (2006b). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525–1538.
Sheridan, P. L. and Hausdorff, J. M. (2007). The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 24, 125–137.
Snijders, J. T. and Verhage, F. (1983). Groninger Intelligentie Test. Lisse: Swets and Zeitlinger.
Snowdon, J., Day, S. and Baker, W. (2006). Current use of psychotropic medication in nursing homes. International Psychogeriatrics, 18, 241–250.
Steffens, D. C. (2008). Separating mood disturbance from mild cognitive impairment in geriatric depression. International Review of Psychiatry, 20, 374–381.
Teng, E. L. and Manly, J. J. (2005). Neuropsychological testing: helpful or harmful? Alzheimer Disease and Associated Disorders, 19, 267–271.
Tsoi, T., Baillon, S. and Lindesay, J. (2008). Early frontal executive impairment as a predictor of subsequent behavior disturbance in dementia. American Journal of Geriatric Psychiatry, 16, 102–108.
Tucker, M. and Hosford, I. (2008). Use of psychotropic medicines in residential care facilities for older people in Hawke's Bay, New Zealand. New Zealand Medical Journal, 121, 18–25.
Valiyeva, E., Herrmann, N., Rochon, P. A., Gill, S. S. and Anderson, G. M. (2008). Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis. Canadian Medical Association Journal, 179, 438–446.
Verhage, F. (1964). Intelligence and Age: Research on Dutch People aged Twelve to Seventy-seven Years Old. [In Dutch: Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar]. Assen: Van Gorcum.
Wadsworth, E. J., Moss, S. C., Simpson, S. A. and Smith, A. P. (2005). Psychotropic medication use and accidents, injuries and cognitive failures. Human Psychopharmacology, 20, 391–400.
Wechsler, D. (1987). Wechsler Memory Scale – Revised. New York: The Psychological Corporation.
Wilson, B., Cockburn, J. and Baddeley, A. (1987). The Rivermead Behavioural Memory Test. Titchfield: Thames Valley Test Company.